| Fish oil as an adjuvant in the treatment of hypertension. | |
| | |
MedLine Citation:
|
PMID: 8820475 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
STUDY OBJECTIVE: To evaluate the effects of omega-3 fatty acids on blood pressure control and lipid levels. DESIGN: Double-blind, placebo-controlled, randomized study. SETTING: Veterans Affairs Medical Center teaching hospital. PATIENTS: Twenty-one men whose blood pressure was not optimally controlled with antihypertensive agents, who met the inclusion criteria. INTERVENTIONS: Patients were randomized to receive either fish oil (4.5 g omega-3 fatty acids/day) or placebo. MEASUREMENTS AND MAIN RESULTS: Blood pressure readings were taken at baseline, and 4 and 8 weeks. Sitting systolic and diastolic blood pressures were significantly reduced in the fish oil group at both week 4 (148/97 to 132/90, p <0.05) and week 8 (148/97 to 134/91, p <0.05). Sitting diastolic blood pressure was significantly reduced in the placebo group at week 8 (94 to 88, p <0.05). There was no difference in percentage change of sitting systolic and diastolic pressures at week 8 comparing the placebo group (-6.4% and -6.3%, respectively) and the fish oil group (-8.8% and -6.6%, respectively). Triglyceride levels (-40.9%, p <0.05) and platelet counts (-8.7%, p <0.05) were significantly reduced at 4 weeks, and low-density lipoprotein (LDL) cholesterol levels were significantly increased both at 4 and 8 weeks (13.5% and 19.1%, respectively) in the fish oil group. CONCLUSION: Adjunctive fish oil supplementation did not substantially augment blood pressure lowering in treated hypertensive men with suboptimally controlled blood pressure. Effects on plasma lipid values were mixed, with an increase in LDL cholesterol and a decrease in plasma triglyceride levels. |
| | |
Authors:
|
D R Gray; C G Gozzip; J H Eastham; M L Kashyap |
Related Documents
:
|
16797745 - Associations of apolipoprotein b with pulse pressure and glucose in chinese families wi... 974435 - The relationship between blood pressure and biochemical risk factors in a general popul... 9794735 - Risk factors associated with alterations in carotid intima-media thickness in hypertens... 15821835 - Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and ... 2142385 - Ascites: its effect upon static inflation of the respiratory system. 9469775 - Intraoperative adjuncts of spinal cord protection. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Pharmacotherapy Volume: 16 ISSN: 0277-0008 ISO Abbreviation: Pharmacotherapy Publication Date: 1996 Mar-Apr |
Date Detail:
|
Created Date: 1996-11-25 Completed Date: 1996-11-25 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8111305 Medline TA: Pharmacotherapy Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 295-300 Citation Subset: IM |
Affiliation:
|
Pharmacy Service, Veterans Affairs Medical Center, Long Beach, CA 90822, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Blood Pressure / drug effects Body Weight Cholesterol / blood Double-Blind Method Fatty Acids, Omega-3 / adverse effects, blood, therapeutic use*, urine Humans Hypertension / therapy* Male Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Acids, Omega-3; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
Next Document: Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction.